MINOVA PHARMA
Latest round
- Series B
Last raised
- Aug 2025
Total raised
- $29M
Investors
- 6
About MINOVA PHARMA
Established in 2021 and based in Nanjing, China, MINOVA PHARMA operates as a pharmaceutical developer that focuses on the field of mental and medical beauty., then established Nanjing Simnovtec pharmaceutical. It was recognized as Nanjing Jiangbei New District Science and Technology Laboratory and Jiangsu Private Science and Technology Enterprise. MINOVA PHARMA focuses on the R&D of mental illness drugs, and medical beauty drugs. The company is equipped with more than 200 sets of R&D equipments, and has a platform for phenotype-based drug screening for disfiguring diseases, a platform for small molecule total synthesis, a platform for evaluation of durability, and a platform for novel drug delivery systems. It has 6 product lines which can be used in curing depression, hair loss, acne, photodamage, various kinds of pigmentation, scarring, abnormal accumulation of localized fat, and other disorders in the field of mental and cosmetic. The company generates revenue through providing the R&D of mental illness drugs, and medical beauty drugs. The company will focus on accelerating the advancement of the innovative drug R&D pipeline, as well as the market promotion and sales layout of its core product "Rongzhi®" lipolysis injection, injecting strong momentum into the company's continued leadership in drug R&D in the consumer healthcare field.
Who invested in MINOVA PHARMA
6 investors across 2 rounds
See all investors in MINOVA PHARMA
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MINOVA PHARMA
Who invested in MINOVA PHARMA?
MINOVA PHARMA has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MINOVA PHARMA raised?
MINOVA PHARMA has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did MINOVA PHARMA last raise money?
MINOVA PHARMA's most recent round on record is a Series B, in Aug 2025.
What does MINOVA PHARMA do?
Established in 2021 and based in Nanjing, China, MINOVA PHARMA operates as a pharmaceutical developer that focuses on the field of mental and medical beauty.
Where is MINOVA PHARMA headquartered?
MINOVA PHARMA is headquartered in Nanjing, China.
Which VCs invest in companies like MINOVA PHARMA?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back pharmaceuticals companies at MINOVA PHARMA's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like MINOVA PHARMA? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.